Trial Profile
Atomoxetine treatment of adults with ADHD [attention-deficit hyperactivity disorder] and comorbid alcohol abuse: a randomized, placebo-controlled trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 01 Jul 2008 Results published in the journal, Drug and Alcohol Dependence.
- 21 Jan 2006 New trial record.